Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
ProductsAiforia® Breast Cancer Ki67

Vendor source

Reviewed 21 Jul 2026

Completeness Good (58%)

Aiforia® Breast Cancer Ki67

Aiforia Technologies Plc

Aiforia® Breast Cancer Ki-67 automatically detects invasive carcinoma and quantifies Ki-67–positive and negative tumor cells in whole slide images (WSI) or selected tissue regions, reducing variability and enhancing diagnostic efficiency.

Supported by 1 paper

Aiforia® Breast Cancer Ki67

Key Features

  • Breast cancer detection
  • Quantification of Ki67-positive and negative tumor cells

General Information

Product name

Aiforia® Breast Cancer Ki67

Modality

Histopathology

Main task

Scoring (IHC quantification)

Subspeciality

Breast pathology

Organ/Specimen source

Not specified

Disease targeted

Breast cancer

Specimen type

Biopsy

Staining

IHC

Stain subtype

KI67

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Directive (IVDD)

Class:

General IVD Devices

Verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Not specified

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Evidence & Research

Technical Specifications

Patient population age

Not specified

Input

whole-slide image, Ki67 IHC

Input format

Not specified

Output

segmentation overlays, object detection overlays, assessment of pathology presence, quantitative area measurements and object counts, automated scoring, draft histopathology report

Output format

Not specified

Integration

Integration via AI marketplace or distribution platform, Integration with hospital reporting system, Integration with IMS (Image Management System), Integration with LMS (Laboratory Management System), Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Hybrid

Trigger for analysis

Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload

Processing time

Not specified

Population

Species: Human, Organ: Breast

Viewer systems

PathPresenter, Sectra, Techcyte

Market Presence

On market since

06-2021

AI Platforms

Sectra Amplifier Store

Resellers

Gaia Science, LIN Trading, Mediq Estonia, Ortomedic, Palex Medical, Quorum Technologies, TeSi Group, Urban Datalab

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Vendor | First published: Jul 30, 2025 | Last updated: Jul 21, 2026

Aiforia® Breast Cancer Ki67 - Aiforia Technologies Plc